AI-related companies now control a share of the S&P 500 that rivals the most dangerous concentration episode in American financial history, and the last time anything came close, investors lost fortunes even as the…
One builds the AI factories, the other makes the chips that power them, yet the market is rewarding only one while punishing the other. Understanding why reveals a deeper split in how investors are…
Two healthcare giants drop their third-quarter numbers on the same morning, and what each reveals about drug costs, insurance margins, and guidance ranges will set the tone for the entire sector heading into 2027.
A Ramsey Show caller earning up to $200,000 a year admitted he has nothing left at the end of the month, and new federal data suggest his situation is far more common among high…
One cruise giant rebuilt its dividend from nothing and is raising it fast, while a casino landlord quietly pays nearly four times the yield. Before you chase either payout, there are risks hiding in…
Starbucks may be eyeing a Chipotle acquisition, but before getting swept up in the excitement, consider what every previous Starbucks headline moment actually delivered to investors who bought in on the news.
Three chip and software giants sent dividend checks to shareholders on the same day, but their records tell very different stories about which boards are sharing their growth and which are quietly holding out.
Suze Orman argues that the wealthiest people she knows share a quiet habit most financial advisors never mention, and it has nothing to do with maxing out a 401(k). Understanding why could change the…
The global luxury market shed tens of millions of shoppers in just a few years, and the shockwaves are still moving through five American stocks with very different chances of surviving the reset.
Analysts slashed their Delta Air Lines earnings estimates below the airline's own guidance, yet nearly all 25 analysts kept their Buy ratings intact. Something has to give when Delta reports Friday morning, and the…
On October 7, three companies with nothing in common sent cash to their shareholders, but the differences in what each paid, how fast each raised it, and what the stock price does to the…
Jim Cramer just stripped PepsiCo of its growth stock label, and on October 8 the company gets one shot to prove him wrong. The numbers management must hit are narrower than most investors realize.
Jim Cramer sees three stocks with very different amounts of bad news or good news already baked into their prices, and figuring out which side each sits on changes everything about whether to buy.
Realty Income earned one of investing's most coveted quality stamps, yet buyers who celebrated the news found themselves holding a stock that went nowhere for years. The milestones that felt like validation turned out…
Eli Lilly's two blockbuster drug approvals that transformed the company into a pharmaceutical giant turned out to be the worst moments to buy the stock. The entry point that crushed every other came during…
Jim Cramer and Clark Howard looked at the same economic threat and reached opposite conclusions about what you should do right now. Understanding why both of them are correct depends entirely on which pile…
Major corporate breakups are reshaping what shareholders own, but one company is doing it twice and another may hand you cash instead of a second stock. Knowing the difference before these deals close could…
Jim Cramer and Wes Moss looked at the same bond selloff and reached opposite conclusions, yet both turned out to be right. The reason comes down to which question each one was actually answering.
AbbVie investors who bought on headline-grabbing drug approvals consistently trailed those who bought during fear and uncertainty. The calendar of milestones reveals a counterintuitive pattern about when good news becomes a trap.
Microsoft has beaten earnings estimates six quarters running while its stock sits roughly where it did a year ago, and Jim Cramer thinks he knows exactly why the market is finally starting to catch…
